Bruker Appoints Robert Rosenthal to Board of Directors
16 November 2015 - 11:00PM
Business Wire
Bruker Corporation (NASDAQ:BRKR) today announced that it has
appointed Dr. Robert Rosenthal to its Board of Directors, effective
immediately.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20151116005463/en/
Dr. Robert Rosenthal Joins Bruker's Board
of Directors (Photo: Business Wire)
Dr. Rosenthal currently serves as Chief Executive Officer and as
a director for Taconic Biosciences, Inc., a privately-held provider
of research models for the pharmaceutical and biotech industry, a
position he has held since joining Taconic Biosciences in June
2014.
Prior to joining Taconic Biosciences, Dr. Rosenthal held a
variety of senior management positions with companies involved in
the development of diagnostics, therapeutics, medical devices, and
life sciences tools, most recently as Chairman and Chief Executive
Officer of Intelligent Medical Implants, AG, a medical technology
company.
He has also served as President and Chief Executive Officer of
Magellan Biosciences, Inc., a provider of clinical diagnostics and
life sciences research tools. Dr. Rosenthal also serves as a
director of Safeguard Scientifics, Inc., a publicly-traded provider
of capital for early- and growth-stage companies, and for Galvanic
Applied Sciences, Inc., a privately held Canadian company. Earlier
in his career, Dr. Rosenthal held senior management positions at
PerkinElmer Inc. and Thermo Fisher Scientific, Inc. He holds a
Ph.D. from Emory University and a Master of Science degree from the
State University of New York.
Frank Laukien, the President and CEO of Bruker, stated: “Dr.
Rosenthal’s success as an entrepreneur, and his extensive
understanding of the diagnostics and life science tools industries,
will make him a valuable addition to our Board. Bob will help to
guide our efforts to create innovative new products and expand into
defensible markets with high margin potential.”
Dr. Rosenthal commented: “Bruker has a long history of
innovation, leadership and success in analytical instrumentation. I
believe there are many opportunities to apply Bruker’s analytical
technologies to new applications and diagnostic areas. I look
forward to assisting Bruker in identifying such new opportunities
for profitable growth, and it is an honor to join the Bruker
board.”
About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve
the quality of human life. Bruker’s high-performance scientific
research instruments and high-value analytical solutions enable
scientists to explore life and materials at molecular, cellular and
microscopic levels.
In close cooperation with our customers, Bruker is enabling
innovation, productivity and customer success in life science
molecular research, in applied and pharma applications, and in
microscopy, nano-analysis and industrial applications, as well as
in cell biology, preclinical imaging, clinical research,
microbiology and molecular diagnostics. For more information,
please visit: http://www.bruker.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151116005463/en/
Bruker CorporationJoshua Young, +1-978-667–9580, ext. 1479Vice
President, Investor Relationsjoshua.young@Bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024